Sherbrooke Park Advisers LLC Care Dx, Inc. Transaction History

Sherbrooke Park Advisers LLC

  • $215 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$17.64 - $25.07 $63,556 - $90,327
-3,603 Reduced 13.97%
22,197 $394 Million
Q4 2024

Feb 14, 2025
BUY
$20.4 - $32.2 $364,854 - $575,897
17,885 Added 225.96%
25,800 $552 Million
Q3 2024

Nov 14, 2024
BUY
$14.41 - $33.99 $114,055 - $269,030
7,915 New
7,915 $247 Million
Q3 2023

Nov 14, 2023
BUY
$7.0 - $11.26 $85,484 - $137,507
12,212 New
12,212 $85.5 Million

Others Institutions Holding CDNA

# of Institutions
201
Shares Held
54.8M
Call Options Held
150K
Put Options Held
57.6K
View Full List

About CareDx, Inc.

CDNA Quotes by TradingView
  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $852M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email